Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers. (Q38148589)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

title

Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

pulmonary tuberculosis

1 reference

based on heuristic

inferred from title

antimicrobial peptide

1 reference

based on heuristic

inferred from title

author

Rogelio Hernández-Pando

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

César E Rivas-Santiago

0 references

author name string

Cesar Enrique Rivas-Santiago

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

Bruno Rivas-Santiago

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

1 reference

1 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1117-1126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24088080 AND SRC:MED&resulttype=core&format=json

Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides

26 February 2020

cites work

1 reference

Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action

21 January 2018

1 reference

Antimicrobial peptides of multicellular organisms

21 January 2018

1 reference

Cathelicidins, multifunctional peptides of the innate immunity

21 January 2018

1 reference

Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils

21 January 2018

1 reference

Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses.

21 January 2018

1 reference

Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs

21 January 2018

1 reference

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

21 January 2018

1 reference

Antimicrobial peptides: premises and promises

21 January 2018

1 reference

Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity

21 January 2018

1 reference

Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis.

21 January 2018

1 reference

Inhibition of iron transport across human intestinal epithelial cells by hepcidin

21 January 2018

1 reference

Immunomodulatory properties of defensins and cathelicidins

21 January 2018

1 reference

A comprehensive summary of LL-37, the factotum human cathelicidin peptide.

21 January 2018

1 reference

Intracellular receptor for human host defense peptide LL-37 in monocytes

21 January 2018

1 reference

Immunomodulatory activities of small host defense peptides

21 January 2018

1 reference

A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis

21 January 2018

1 reference

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

21 January 2018

1 reference

Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.

21 January 2018

1 reference

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

21 January 2018

1 reference

Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4.

21 January 2018

1 reference

Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.

21 January 2018

1 reference

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

21 January 2018

1 reference

An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

21 January 2018

1 reference

Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3.

21 January 2018

1 reference

The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.

21 January 2018

1 reference

Expression of beta defensin 2 in experimental pulmonary tuberculosis: tentative approach for vaccine development.

21 January 2018

1 reference

Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.

21 January 2018

1 reference

Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells

21 January 2018

1 reference

Defensins as anti-inflammatory compounds and mucosal adjuvants

21 January 2018

1 reference

The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo

21 January 2018

1 reference

Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences

21 January 2018

1 reference

Human alpha-defensins inhibit Clostridium difficile toxin B.

21 January 2018

1 reference

Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study

21 January 2018

1 reference

Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis

21 January 2018

1 reference

Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells

21 January 2018

1 reference

Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells

21 January 2018

1 reference

Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis.

21 January 2018

1 reference

Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus.

21 January 2018

1 reference

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

21 January 2018

1 reference

Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin

21 January 2018

1 reference

Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin.

21 January 2018

1 reference

High-throughput generation of small antibacterial peptides with improved activity

21 January 2018

1 reference

Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models

21 January 2018

1 reference

An essential amino acid induces epithelial beta -defensin expression

21 January 2018

1 reference

Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis

21 January 2018

1 reference

Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis

21 January 2018

1 reference

Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohort

21 January 2018

1 reference

Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis

21 January 2018

1 reference

Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic

21 January 2018

1 reference

Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy

21 January 2018

1 reference

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

Phenylbutyrate induces antimicrobial peptide expression

21 January 2018

1 reference

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

21 January 2018

1 reference

Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial

21 January 2018

1 reference

Lantibiotics: diverse activities and unique modes of action

21 January 2018

1 reference

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

21 January 2018

1 reference

Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs

21 January 2018

1 reference

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity

21 January 2018

1 reference

Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets

21 January 2018

1 reference

Innate defense regulator peptide synergizes with CpG ODN for enhanced innate intestinal immune responses in neonate piglets

21 January 2018

1 reference

Modulating immunity as a therapy for bacterial infections

21 January 2018

1 reference

Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy

21 January 2018

1 reference

Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis

21 January 2018

1 reference

Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91.

21 January 2018

1 reference

DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H37Ra

21 January 2018

1 reference

Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2.

21 January 2018

1 reference

beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved

21 January 2018

1 reference

Deciphering the Mode of Action of the Synthetic Antimicrobial Peptide Bac8c

21 January 2018

1 reference

Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment

21 January 2018

1 reference

Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria

21 January 2018

1 reference